WHC is still in active development. Read this to understand our approach.
depiction of UIQMVEYFGZJHCZ-UHFFFAOYSA-N.svg
isomerdesign

17-(Prop-2-en-1-yl)-...

Verificar en isomerdesign

pubchem

Nalorphine

Verificar en pubchem

drugmap

Nalorphine

Verificar en drugmap

wiki

Nalorphine

Verificar en wiki

Data

InChI: InChI=1S/C19H21NO3/c1-2-8-20-9-7-19-12-4-6-15(22)18(19)23-17-14(21)5-3-11(16(17)19)10-13(12)20/h2-6,12-13,15,18,21-22H,1,7-10H2

Sinónimos: Nalorfina, Nalorphin,UNII-U59WB2WRY2,CHEBI:7458,(5α,6α)-17-(Prop-2-en-1-yl)-7,8-didehydro-4,5-epoxymorphinan-3,6-diol,Anthorphine,Antorphine,Morphinan-3,6-diol, 7,8-didehydro-4,5-epoxy-17-(2-propenyl)-, (5alpha,6alpha)-,EINECS 200-546-1,Nalorphine serb,Anarcon,DEA No. 9400, 62-67-9,Nallin,N-allyl-normorphine,17-(Prop-2-en-1-yl)-7,8-didehydro-4,5α-epoxymorphinan-3,6α-diol, Nalorphine [INN:BAN],ZINC3875420,BDBM50367061,Norfin, Morphinan-3,6-diol, 7,8-didehydro-4,5-epoxy-17-(2-propenyl)-, (5alpha,6alpha)-,Antorfin, Acetorfin, Normorphine, N-allyl-,(4R,4aR,7S,7aR,12bS)-3-allyl-2,4,4a,7,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinoline-7,9-diol,Nalorphine, Antorphine, N-Allyl-7,8-dehydro-4,5-epoxy-3,6-dihydroxymorphinan,7,8-Didehydro-4,5-epoxy-17-(2-propenyl)morphinan-3,6-diol,Nalorfina [DCIT],N-Allyl-N-desmethylmorphine, U59WB2WRY2,NALORPHINE [MI],Nalorfina,DTXSID3023348,Antorphin, UNII-U59WB2WRY2,Nalorphinium,PDSP2_001572, EINECS 200-546-1,Morphinan-3,6-alpha-diol, 17-allyl-7,8-didehydro-4,5-alpha-epoxy-,Nalorphin,Nalorphinum [INN-Latin], Nalorphinium,N-Allyl-7,8-dehydro-4,5-epoxy-3,6-dihydroxymorphinan, N-Allylnormorphine, Antorfin, Anarcon,Nalorphinum,Acetorfin [Czech], Nallin,Acetorfin,NALORPHINE [MART.], N-Allyl-N-desmethylmorphine,Allorphine, Acetorfin [Czech],GTPL1629,HSDB 3278,Q2622916, Nalorphinum [INN-Latin],(5alpha,6alpha)-17-prop-2-en-1-yl-7,8-didehydro-4,5-epoxymorphinan-3,6-diol,(1S,5R,13R,14S,17R)-4-(prop-2-en-1-yl)-12-oxa-4-azapentacyclo[9.6.1.0^{1,13}.0^{5,17}.0^{7,18}]octadeca-7(18),8,10,15-tetraene-10,14-diol,MORPHINAN-3,6-DIOL, 7,8-DIDEHYDRO-4,5-EPOXY-17-(2-PROPENYL)-(5.ALPHA.,6.ALPHA.)-,SCHEMBL38920,NALORPHINE [INN], DEA No. 9400,Normorphine, N-allyl-,NALORPHINE [HSDB], Norfin,NANM,NALORPHINE [WHO-DD],62-67-9,CHEMBL415284, Nalorfina [DCIT],NCGC00168255-01, Antorphin,Nalorphine [INN:BAN],DB11490,D08247, Anthorphine,(4R,4aR,7S,7aR,12bS)-3-(Prop-2-en-1-yl)-2,3,4,4a,7,7a-hexahydro-1H-4,12-methano[1]benzofuro[3,2-e]isoquinoline-7,9-diol,Nalorphine (INN),U59WB2WRY2, Allorphine,N-Allylnormorphine, CHEBI:7458, HSDB 3278,Nalorphine serb (TN), NANM

Estimated data

Solubilidad: -2.825 (log(S) in mol/L prediction using SolTranNet)

Blood Brain Barrier Permeability: Yes (prediction using frontiersin.org)

Addictivity Prediction: 97.6% (prediction based on www.mdpi.com)

Similitudes

The following is a set of comparisons to understand the properties of this compound. This is still higly experimental and is still under active development. Please refer to our series of blog posts to fully understand our approach and its limitations. This information is for informational purposes only and should not be construed as medical advice.